{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:32:06Z","timestamp":1762900326009,"version":"3.41.2"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Joint pain and arthralgia can be manifestations of COVID-19, and studies evaluating long COVID symptoms identified the persistence of these disorders. Moreover, some case reports highlighted the development of new inflammatory arthritis in patients with COVID-19, suggesting a possible relation. Viral infections and rheumatic diseases share a documented relationship; they have been associated with genetic and environmental risk factors responsible for some of them. There is crosstalk between viruses and the immune system during the development of several rheumatic diseases. Moreover, infections may participate in the pathogenesis of autoimmune rheumatic diseases and contribute to patient mortality. Therefore, it is crucial to provide a clearer insight into the interaction between viral infections and rheumatic diseases. Here, we provide a mini-review of the current literature with the aim of shedding light on the relationship between COVID-19 and rheumatic or musculoskeletal diseases, which is still unclear. Specifically, we examined several aspects: risk for the rheumatic population of acquiring the virus or developing severe symptoms, similarities of COVID-19 and arthritis, the possible rheumatic consequence of COVID-19, of rheumatic drugs and vaccines, and COVID-19 prevention in rheumatic patients through vaccination.<\/jats:p>","DOI":"10.3389\/fmed.2022.997876","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T06:41:46Z","timestamp":1664174506000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["COVID-19 and rheumatic diseases: A mini-review"],"prefix":"10.3389","volume":"9","author":[{"given":"Livia","family":"Roseti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brunella","family":"Grigolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00296-021-04998-x","article-title":"Reactive arthritis after COVID-19: a case-based review","volume":"41","author":"Kocyigit","year":"2021","journal-title":"Rheumatol Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/biom11070993","article-title":"COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies","volume":"11","author":"Raman","year":"2021","journal-title":"Biomolecules."},{"key":"B5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41584-022-00755-x","article-title":"COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations","volume":"18","author":"Grainger","year":"2022","journal-title":"Nat Rev Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"101657","DOI":"10.1016\/j.berh.2020.101657","article-title":"Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes","volume":"35","author":"Grainger","year":"2021","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2020-217877","article-title":"EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2","volume":"79","author":"Landew\u00e9","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/art.41596","article-title":"American college of rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3","volume":"73","author":"Mikuls","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.18773\/austprescr.2020.058","article-title":"Management of autoimmune disease during the COVID-19 pandemic","volume":"43","author":"Robinson","year":"2020","journal-title":"Aust Prescr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"W86","DOI":"10.7326\/L20-0948","article-title":"Update alert 6: masks for prevention of respiratory virus infections, including SARS-CoV-2, in health care and community settings","volume":"173","author":"Chou","year":"2020","journal-title":"Ann Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.reumae.2012.10.004","article-title":"Of bugs and joints: the relationship between infection and joints","volume":"9","author":"Espinoza","year":"2013","journal-title":"Reumatol Clin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"789882","DOI":"10.3389\/fmicb.2022.789882","article-title":"The complexity of SARS-CoV-2 infection and the COVID-19 pandemic","volume":"13","author":"da Silva Torres","year":"2022","journal-title":"Front Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science."},{"key":"B16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fpubh.2020.00383","article-title":"COVID-19: a multidisciplinary review","volume":"8","author":"Chams","year":"2020","journal-title":"Front Public Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: immunopathogenesis and Immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","article-title":"Long covid-mechanisms, risk factors, and management","volume":"374","author":"Crook","year":"2021","journal-title":"BMJ."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2020.22717","article-title":"A Proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications","volume":"324","author":"Datta","year":"2020","journal-title":"JAMA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1126\/science.abc6197","article-title":"Reducing transmission of SARS-CoV-2","volume":"368","author":"Prather","year":"2020","journal-title":"Science."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-15-8323-0","volume-title":"Skills in Rheumatology.","author":"Almoallim","year":"2021"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.trsl.2021.02.010","article-title":"Inflammatory arthritis in patients with COVID-19","volume":"232","author":"Conway","year":"2021","journal-title":"Transl Res."},{"key":"B26","first-page":"1","article-title":"\u201cThe spectrum of rheumatic diseases\u201d","volume-title":"The Handbook of Systemic Autoimmune Diseases","author":"Calle","year":"2018"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B28","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10067-022-06120-3","article-title":"Reactive arthritis before and after the onset of the COVID-19 pandemic","volume":"41","author":"Bekaryssova","year":"2022","journal-title":"Clin Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"808608","DOI":"10.3389\/fmed.2021.808608","article-title":"COVID GEAS: COVID-19 national survey in patients with systemic autoimmune diseases","volume":"8","author":"Borja Del Carmelo","year":"2021","journal-title":"Kk Front Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/art.41388","article-title":"Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?","volume":"72","author":"Favalli","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 global rheumatology alliance physician-reported registry","volume":"80","author":"Strangfeld","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2106\/JBJS.20.00847","article-title":"Musculoskeletal consequences of COVID-19","volume":"102","author":"Disser","year":"2020","journal-title":"J Bone Joint Surg Am."},{"key":"B35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/cpt.1910","article-title":"Management of osteoarthritis during the COVID-19 pandemic","volume":"108","author":"Ragni","year":"2020","journal-title":"Clin Pharmacol Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/ijms23020720","article-title":"COVID-19 in joint ageing and osteoarthritis: current status and perspectives","volume":"23","author":"Lauwers","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.3390\/cells10123291","article-title":"COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges","volume":"10","author":"Dewanjee","year":"2021","journal-title":"Cells."},{"key":"B38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis","volume":"326","year":"2021","journal-title":"JAMA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0267-6","article-title":"IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes","volume":"51","author":"Bonelli","year":"2019","journal-title":"Exp Mol Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e147413","DOI":"10.1172\/jci.insight.147413","article-title":"COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes","volume":"6","author":"MacDonald","year":"2021","journal-title":"JCI Insight."},{"key":"B41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.41469","article-title":"Antirheumatic disease therapies for the treatment of COVID-19: a systematic review and meta-analysis","volume":"73","author":"Putman","year":"2021","journal-title":"Arthritis Rheum."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s10067-020-05189-y","article-title":"COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments","volume":"39","author":"Ou\u00e9draogo","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-020-04639-9","article-title":"Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment","volume":"10","author":"Shah","year":"2020","journal-title":"Rheumatol Int."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1101\/2022.02.08.22270696","article-title":"DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: a prospective study","author":"Di Iorio","year":"2022","journal-title":"Arthritis Rheum"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1007\/s10067-021-05691-x","article-title":"COVID-19 and the clinical course of rheumatic manifestations","volume":"40","author":"Ahmed","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-020-0451-z","article-title":"COVID-19 revisiting inflammatory pathways of arthritis","volume":"16","author":"Schett","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s42358-021-00204-5","article-title":"Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders","volume":"61","author":"Ruscitti","year":"2021","journal-title":"Adv Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1002\/jmv.27229","article-title":"SARS-CoV2-triggered acute arthritis: viral arthritis rather than reactive arthritis","volume":"93","author":"Kobayashi","year":"2021","journal-title":"J Med Virol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218520","article-title":"Transient monoarthritis and psoriatic skin lesions following COVID-19","author":"De Stefano","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab009","article-title":"Axial presentation of reactive arthritis secondary to Covid-19 infection","author":"Coath","year":"2021","journal-title":"Rheumatology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1136\/annrheumdis-2020-217914","article-title":"Case series of acute arthritis during COVID-19 admission","volume":"80","author":"L\u00f3pez-Gonz\u00e1lez","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.003","article-title":"Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2: a systematic review","volume":"226","author":"Abrams","year":"2020","journal-title":"J Pediatr"},{"key":"B53","doi-asserted-by":"publisher","first-page":"110638","DOI":"10.1016\/j.mehy.2021.110638","article-title":"Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: a causal link?","volume":"153","author":"Roncati","year":"2021","journal-title":"Med Hypotheses."},{"key":"B54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/ard.2004.023200","article-title":"Antimalarial myopathy: an underdiagnosed complication? prospective longitudinal study of 119 patients","volume":"65","author":"Casado","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/TCRM.S3285","article-title":"Lopinavir\/ritonavir in the treatment of HIV-1 infection: a review","volume":"4","author":"Chandwani","year":"2008","journal-title":"Ther Clin Risk Manag."},{"key":"B56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0973-6883(12)60090-5","article-title":"A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infection","volume":"2","author":"Naik","year":"2012","journal-title":"J Clin Exp Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/rheumatology\/kew431","article-title":"Type I interferon\u2013mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy","volume":"56","author":"Psarras","year":"2017","journal-title":"Rheumatology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijid.2022.04.027","article-title":"Humoral and cellular responses to spike of \u03b4 SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases","volume":"121","author":"Petrone","year":"2022","journal-title":"Int J Infect Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1007\/s10067-021-05700-z","article-title":"A practical approach for vaccinations including COVID-19 in autoimmune\/autoinflammatory rheumatic diseases: a non-systematic review","volume":"40","author":"Soy","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"112385","DOI":"10.1016\/j.biopha.2021.112385","article-title":"Chemically modified mRNA beyond COVID-19: potential preventive and therapeutic applications for targeting chronic diseases","volume":"145","author":"Elkhalifa","year":"2022","journal-title":"Biomed Pharmacother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e001041","DOI":"10.1136\/rmdopen-2019-001041","article-title":"Incidence and prevalence of vaccine preventable infections in adult patients with auto-immune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD","volume":"5","author":"Furer","year":"2019","journal-title":"RMD open."},{"key":"B62","doi-asserted-by":"publisher","first-page":"SI180","DOI":"10.1093\/rheumatology\/keac089","article-title":"Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions","volume":"61","author":"Krasselt","year":"2022","journal-title":"Rheumatology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"919979","DOI":"10.3389\/fimmu.2022.919979","article-title":"The flare of rheumatic disease after SARS-CoV-2 vaccination: a review","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1080\/21645515.2021.1920274","article-title":"Reactive arthritis after COVID- 19 vaccination","volume":"17","author":"An","year":"2021","journal-title":"Hum Vaccin Immunother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"108256","DOI":"10.1016\/j.intimp.2021.108256","article-title":"Arthritis following COVID-19 vaccination: report of two cases","volume":"101","author":"Unal Enginar","year":"2021","journal-title":"Int Immunopharmacol."},{"journal-title":"SARS-CoV-2-Vaccine-Inactivated-Sinovac-Biotech","year":"2022","key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s40278-022-09226-x"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/1756-185X.14202","article-title":"Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection","volume":"24","author":"Baimukhamedov","year":"2021","journal-title":"Int J Rheum Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/1756-185X.14220","article-title":"Seropositive rheumatoid arthritis after vaccination against SARSCoV-2 infection","volume":"24","author":"Baimukhamedov","year":"2021","journal-title":"Int J Rheum Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/biomedicines10040834","article-title":"Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis","volume":"10","author":"Tang","year":"2022","journal-title":"Biomedicines."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1002\/art.41928","article-title":"American college of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3","volume":"73","author":"Curtis","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/art.41924","article-title":"Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two-dose SARS-CoV-2 messenger RNA vaccination","volume":"74","author":"Connolly","year":"2022","journal-title":"Arthritis Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.997876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T06:41:54Z","timestamp":1664174514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.997876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":71,"alternative-id":["10.3389\/fmed.2022.997876"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.997876","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"article-number":"997876"}}